• Accelero_Spring_2017_1.jpg
  • Accelero_Spring_2017_2.jpg
  • Accelero_Spring_2017_3.jpg
  • Accelero_Spring_2017_4.jpg
  • Accelero_Spring_2017_5.jpg
  • Accelero_Spring_2017_6.jpg
  • Accelero_Spring_2017_7.jpg
  • Accelero_Spring_2017_8.jpg
  • Accelero_Spring_2017_9.jpg

Immune response to vaccines: plasmids, modified vaccinia Ankara (MVA) based vaccines, RNA transcripts, etc

Immune response to Active Pharmaceutical Ingredients (API) like siRNA, antisense oligos, microRNA antagomirs and mimics, plasmid vaccines, linearized DNA vectors

Immune response to Advanced Therapy Medicinal Products (ATMP) like cell-based therapeutics or genetic engineered nucleic acids

Immunogenicity Testing (IgM, total IgG, IgG subclasses)

Immune response to biopharmaceutical products like proteins, hormones, monoclonal antibodies, peptides, etc according to the EMA Guideline on biotechnology-derived therapeutic proteins.



Last update of this site: 13-OCT-2016 by Christian Lange